Assenagon Asset Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-91,886
| Closed | -$1.27M | – | 1259 |
|
|
2021
Q2 | $1.27M | Buy |
91,886
+16,370
| +22% | +$226K | ﹤0.01% | 837 |
|
|
2021
Q1 | $1.1M | Buy |
75,516
+12,577
| +20% | +$184K | ﹤0.01% | 874 |
|
|
2020
Q4 | $1.09M | Buy |
62,939
+15,400
| +32% | +$268K | ﹤0.01% | 675 |
|
|
2020
Q3 | $872K | Sell |
47,539
-2,527
| -5% | -$46.4K | ﹤0.01% | 835 |
|
|
2020
Q2 | $894K | Buy |
+50,066
| New | +$894K | 0.01% | 801 |
|